Similar Articles
31 Association of interferon lambda-4 rs12979860 polymorphism with hepatocellular carcinoma in patients with chronic hepatitis C infection
32 Screening for scoliosis - New recommendations, old dilemmas, no straight solutions
33 Emergency department targeted screening for hepatitis C does not improve linkage to care
34 GOECP/SEOR clinical recommendations for lung cancer radiotherapy during the COVID-19 pandemic
35 Assessment of lncRNA GAS5, lncRNA HEIH, lncRNA BISPR and its mRNA BST2 as serum innovative non-invasive biomarkers: Recent insights into Egyptian patients with hepatitis C virus type 4
36 Expanding the donor pool: Hepatitis C, hepatitis B and human immunodeficiency virus-positive donors in liver transplantation
37 Moving forward on the pathway of cell-based therapies in ischemic heart disease and heart failure – time for new recommendations?
38 Hepatitis C virus cure with direct acting antivirals: Clinical, economic, societal and patient value for China
39 Ombitasvir/paritaprevir/ritonavir + dasabuvir +/- ribavirin in real world hepatitis C patients
40 Leukocytoclastic vasculitis caused by hepatitis C virus in a liver transplant recipient: A case report
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA